Disparities in prostate cancer diagnoses in persons experiencing homelessness.

Authors

null

Zachary S Mayo

Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Zachary S Mayo , Sean M. Parker , Sarah S Kilic , Jeremy Weleff , Colleen Strzalka , Michael P. Phelan , Omar Y. Mian , Kevin L. Stephans , John H. Suh , Rahul D. Tendulkar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Cancer Disparities

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 24)

DOI

10.1200/JCO.2023.41.6_suppl.24

Abstract #

24

Poster Bd #

A8

Abstract Disclosures

Similar Posters

Poster

2013 Genitourinary Cancers Symposium

PSA-detected prostate cancer in the United States: A population-based study of 70,345 men with AJCC stage T1cN0M0 disease.

PSA-detected prostate cancer in the United States: A population-based study of 70,345 men with AJCC stage T1cN0M0 disease.

First Author: Hong Zhang

Poster

2024 ASCO Genitourinary Cancers Symposium

Rapid quantification of prostate specific antigen (PSA) from fingerstick (FS) blood.

Rapid quantification of prostate specific antigen (PSA) from fingerstick (FS) blood.

First Author: Joseph Earl Thomas

Poster

2023 ASCO Annual Meeting

The performance of prostate specific antigen (PSA) testing in the population based NPCC cohort.

The performance of prostate specific antigen (PSA) testing in the population based NPCC cohort.

First Author: Jan Oldenburg

Poster

2023 ASCO Genitourinary Cancers Symposium

Germline testing for men with prostate cancer: Need to broaden the indications in Europe?

Germline testing for men with prostate cancer: Need to broaden the indications in Europe?

First Author: Elena Trevisi